New Penn-Designed Gel Allows for Targeted Therapy After Heart Attack

Combatting the tissue degrading enzymes that cause lasting damage following a heart attack is tricky. Each patient responds to a heart attack differently and damage can vary from one part of the heart muscle to another, but existing treatments can’t be fine-tuned to deal with this variation. 

Tailoring Treatment for Triple-Negative Breast Cancer

Intravitreal hydrogels for sustained release of therapeutic proteins - ScienceDirect

Factors Influencing Retention of Injected Biomaterials to Treat Myocardial Infarction - Schotman - 2022 - Advanced Materials Interfaces - Wiley Online Library

First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial

Recent Developments in Cardiovascular Stem Cells

Frontiers Proinflammatory mediators, TNFα, IFNγ, and thrombin, directly induce lymphatic capillary tube regression

Hyaluronan and elastin-like protein (HELP) gels significantly improve microsphere retention in the myocardium - Biomaterials Science (RSC Publishing) DOI:10.1039/D1BM01890F

Targeting miR-30d reverses pathological cardiac hypertrophy - eBioMedicine

Penn preclinical trial discovers potential of CAR-T gel in eliminating residual cancer cells

Phenytoin 5%/Nifedipine 2%/Misoprostol 0.0024% Topical Gel, Formulas

Factors Influencing Retention of Injected Biomaterials to Treat Myocardial Infarction - Schotman - 2022 - Advanced Materials Interfaces - Wiley Online Library

Molecules, Free Full-Text

Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma